Suppr超能文献

利用 CRISPR/Cas 筛选和数据库发现人类癌症中的有效和新颖的药物靶点。

To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases.

机构信息

Department of Comprehensive Pathology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.

出版信息

Int J Mol Sci. 2021 Nov 15;22(22):12322. doi: 10.3390/ijms222212322.

Abstract

CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic lethality is defined as multiple genetic abnormalities that, when present individually, do not affect function or survival, but when present together, are lethal. Recently, many CRISPR libraries are available, and the latest libraries are more accurate and can be applied to few cells. However, it is easier to efficiently search for cancer targets with their own screenings by effectively using databases of CRISPR screenings, such as Depmap portal, PICKLES (Pooled In-Vitro CRISPR Knockout Library Essentiality Screens), iCSDB, Project Score database, and CRISP-view. This review will suggest recent optimal CRISPR libraries and effective databases for Novel Approaches in the Discovery and Design of Targeted Therapies.

摘要

CRISPR/Cas 已经成为一种出色的基因编辑技术,在全球范围内被用于研究。CRISPR 文库是鉴定人类癌症中用于癌症治疗的必需基因和合成致死性的理想工具。合成致死性定义为多种遗传异常,单独存在时不会影响功能或生存,但同时存在时则是致命的。最近,有许多 CRISPR 文库可用,最新的文库更准确,可以应用于少量细胞。然而,通过有效利用 CRISPR 筛选数据库,例如 Depmap 门户、PICKLES(Pooled In-Vitro CRISPR Knockout Library Essentiality Screens)、iCSDB、Project Score 数据库和 CRISP-view,可以更有效地进行自身筛选,从而更容易有效地搜索癌症靶点。本综述将为靶向治疗的发现和设计中的新方法推荐最近的最佳 CRISPR 文库和有效的数据库。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/481f/8622676/d127de91742a/ijms-22-12322-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验